ExploreWatchlistsPricing
  1. US-listed companies
  2. Axsome Therapeutics, Inc.
  3. Financials
  4. Long-term debt, non-current

Axsome Therapeutics, Inc. (AXSM)

Market cap
$12.1B
P/E ratio
SummaryFinancials
Period EndLong-term debt, non-current (Million USD)YoY (%)
Dec 31, 2025118-34.84%
Dec 31, 2024181+1.48%
Dec 31, 2023178+88.92%
Dec 31, 202294+92.01%
Dec 31, 202149+1.59%
Dec 31, 202048+178.79%
Dec 31, 201917+378.88%
Dec 31, 20184-45.68%
Dec 31, 20177-29.64%
Dec 31, 20169

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat